Nonequivalent response to bromodomain-targeting BET inhibitors in oligodendrocyte cell fate decision

Research output: Contribution to journalShort surveypeer-review

19 Scopus citations

Abstract

The tandem bromodomains (BD1 and BD2) of the BET family proteins BRD2, BRD3, BRD4, and BRDT are structurally conserved but not functionally equivalent. In this issue of Chemistry & Biology, Gacias and colleagues report that a BD1-specific chemical inhibitor, Olinone, enhances oligodendrocyte differentiation, contrasting the reverse process triggered by broad BD1/BD2-targeting inhibitors, highlighting distinct roles of BD1 and BD2 in cell fate decision.

Original languageEnglish (US)
Pages (from-to)804-806
Number of pages3
JournalChemistry and Biology
Volume21
Issue number7
DOIs
StatePublished - Jul 17 2014

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'Nonequivalent response to bromodomain-targeting BET inhibitors in oligodendrocyte cell fate decision'. Together they form a unique fingerprint.

Cite this